The hepatitis A vaccine provides protection for approximately one year following a single dose, with a booster dose given six to twelve months later extending this to at least 25 years and likely lifelong for most recipients. The duration of protection depends on whether you have received just the first dose or whether you have completed the full two-dose course; a distinction that has significant implications for how long you can travel to hepatitis A endemic regions without requiring re-vaccination. Anyone who received their first hepatitis A vaccine dose some years ago but never returned for the booster should be aware that their protection is likely to have waned, making a review of their vaccination history strongly advisable before travelling to any high-risk destination. At Perfect Meds, our expert pharmacists can review your hepatitis A vaccination history, advise on whether a booster is due, and administer any required doses in a single convenient appointment ahead of your travel.
Book now to arrange your hepatitis A vaccination review at Perfect Meds.
A single dose of the hepatitis A vaccine begins to provide protection within two to four weeks and offers cover for approximately one year. A booster dose given six to twelve months after the first dose extends protection to at least 25 years and is expected to provide lifelong immunity for most recipients. No further routine boosters are recommended after the completion of the two-dose course for the general population, making hepatitis A one of the most straightforwardly managed travel vaccinations available. At Perfect Meds, our expert pharmacists can review your vaccination history and ensure your hepatitis A protection is current before your next trip to a high-risk destination.
The Importance of Hepatitis A Vaccination
Hepatitis A is a contagious viral liver infection caused by the hepatitis A virus (HAV), transmitted primarily through the consumption of food or water contaminated with the faeces of an infected person. It is associated with inadequate sanitation infrastructure and limited access to clean water, making it endemic in many parts of the world that are popular travel destinations for UK residents, including parts of Africa, Asia, Central and South America, and Eastern Europe. Unlike hepatitis B and C, hepatitis A does not cause chronic liver disease, but it can cause severe acute illness lasting several weeks to months, and in older adults and those with pre-existing liver conditions, it can lead to life-threatening complications including acute liver failure.
According to the World Health Organization, there are an estimated 1.4 million cases of hepatitis A globally each year, though the true incidence is likely significantly higher due to widespread underreporting in endemic regions. Symptoms of hepatitis A typically develop two to four weeks after infection and include fatigue, nausea, abdominal discomfort, loss of appetite, dark urine, and jaundice; the yellowing of the skin and eyes caused by liver inflammation. Most people recover fully from hepatitis A without specific treatment, but the illness can be debilitating and disruptive, and for vulnerable groups the consequences can be severe. Vaccination is by far the most effective way to protect against hepatitis A, and the high efficacy and long duration of protection offered by the available vaccines make it one of the most straightforward and impactful travel health decisions any traveller can make.
The Hepatitis A Vaccine — How it Works
The hepatitis A vaccine is an inactivated vaccine; it contains killed hepatitis A virus particles that stimulate the immune system to produce protective antibodies without the ability to cause hepatitis A infection. This makes it safe for use across a very wide range of patient groups, including immunocompromised individuals, pregnant women (following appropriate risk-benefit assessment), and older adults. Upon vaccination, the immune system recognises the inactivated virus particles as foreign and mounts an immune response, producing antibodies that remain in circulation for a period and, crucially, generating immunological memory that allows a rapid and robust response if the real virus is encountered in the future.
The hepatitis A vaccine is available in the UK both as a standalone vaccine and in combination with other antigens. The most widely used standalone hepatitis A vaccines in the UK include Havrix Monodose and Epaxal, both of which are given as a single intramuscular injection. Combination vaccines are also available; most notably Twinrix, which combines hepatitis A and hepatitis B antigens in a single injection, and Hepatyrix and ViATIM, which combine hepatitis A with typhoid fever antigens. These combination vaccines are particularly practical for travellers who require protection against multiple diseases, reducing the number of injections required and simplifying the pre-travel vaccination process.
How Long Does the Hepatitis A Vaccine Last?
The duration of protection offered by the hepatitis A vaccine is one of its most important and clinically relevant characteristics, and it varies significantly depending on whether the individual has received one dose or two. The table below provides a clear summary of the protection offered by each stage of the hepatitis A vaccination course, including the recommended timing of the booster dose and the expected duration of protection at each stage.
| Stage | Timing | Protection Onset | Duration of Protection | Notes |
|---|---|---|---|---|
| Dose 1 (Primary) | Day 0 | 2 to 4 weeks after injection | Approximately 1 year | Administer at least 2 weeks before travel |
| Dose 2 (Booster) | 6 to 12 months after dose 1 | Rapidly — within days of booster | At least 25 years, likely lifelong | No further routine boosters recommended after full course |
| Twinrix (Hep A + Hep B) | 0, 1, and 6 months | After dose 2 (partial); full after dose 3 | At least 25 years (Hep A); long-term (Hep B) | Convenient combination for travellers needing both |
| Hepatyrix / ViATIM (Hep A + Typhoid) | Single injection | 2 to 4 weeks after injection | 1 year (Hep A single dose); up to 3 years (typhoid) | Hep A booster required at 6 to 12 months for long-term cover |
| Late Booster (beyond 12 months) | Up to several years after dose 1 | Rapidly — anamnestic response | At least 25 years, likely lifelong | No need to restart course if booster delayed beyond 12 months |
One of the most practically reassuring aspects of the hepatitis A vaccination schedule is that the booster dose does not need to be given exactly at the six to twelve month window; studies have shown that the anamnestic (memory) immune response to the booster is preserved even when it is given several years after the first dose. This means that travellers who received their first dose and then never returned for the booster do not need to restart the two-dose course from scratch; a single booster dose at any point will complete their long-term protection.
Not sure whether your hepatitis A vaccination is up to date? Our expert pharmacists can check your records and advise. Call us to get your vaccination history reviewed at Perfect Meds today.
Who Needs the Hepatitis A Vaccine?
The hepatitis A vaccine is recommended for a wide range of individuals; both travellers visiting high-risk destinations and certain groups within the UK who are at elevated risk of exposure through non-travel-related routes. In the UK, the hepatitis A vaccine is available on the NHS for specific at-risk groups, whilst the majority of travellers will need to access it through a private travel clinic or registered pharmacy.
Groups Recommended to Receive the Hepatitis A Vaccine
- Travellers visiting countries or regions where hepatitis A is endemic, including parts of Africa, Asia, Central and South America, Eastern Europe, and the Middle East; particularly those who may eat locally prepared food, drink tap water, or have contact with local populations in settings with limited sanitation.
- People with chronic liver disease, including those with hepatitis B or C, cirrhosis, or alcohol-related liver disease, who are at significantly higher risk of severe complications if they contract hepatitis A.
- Men who have sex with men (MSM), who are at elevated risk due to specific transmission routes associated with close personal contact.
- People who inject drugs, in whom outbreaks of hepatitis A have been documented in the UK and other countries.
- Those who work with hepatitis A in a laboratory setting, or who work in environments where exposure to the virus is a recognised occupational risk.
- Individuals who are in close household or sexual contact with a person who has been diagnosed with hepatitis A.
- Haemophiliacs and others who receive regular blood products, in whom hepatitis A infection can cause more serious illness.
- Those travelling to or from countries where hepatitis A is endemic who may transmit the infection to vulnerable contacts upon return to the UK.
Hepatitis A and Travel — The Highest-Risk Destinations
Hepatitis A is endemic across much of the developing world, and understanding which specific destinations carry the highest risk is important for making an informed decision about vaccination. The risk of hepatitis A in any given destination is closely linked to the standard of local water treatment, sanitation infrastructure, and food hygiene practices; factors that can vary considerably not only between countries but between different regions within the same country.
The highest-risk destinations for hepatitis A include the Indian subcontinent, particularly India, Pakistan, Bangladesh, Nepal, and Sri Lanka, where the virus is highly endemic and where travellers are frequently exposed to contaminated food and water. Sub-Saharan Africa presents a similarly high risk, with poor sanitation infrastructure in many rural and urban areas creating conditions in which hepatitis A transmission thrives. Southeast Asia, including Thailand, Vietnam, Cambodia, Indonesia, and the Philippines, carries significant hepatitis A risk, as does Central and South America, particularly in countries with limited public health infrastructure. Eastern Europe and parts of the Middle East also carry higher rates of hepatitis A than Western Europe, though the risk is generally lower than in the regions listed above.
Hepatitis A is just one of several vaccine-preventable diseases that travellers to these regions need to be aware of, and knowing your full vaccination requirements well in advance of departure is an essential part of responsible travel health preparation. Enter your destination below to get an instant overview of the travel vaccinations and health precautions that may be recommended for your specific itinerary, including whether the hepatitis A vaccine should form part of your pre-travel health plan:
Can the Hepatitis A Vaccine Be Given at the Same Time as Other Vaccines?
Yes. The hepatitis A vaccine can be administered simultaneously with most other travel and routine vaccines without any meaningful reduction in the efficacy of any of the vaccines involved or any increased risk of side effects. This is an important practical consideration for travellers who require multiple vaccines before departure and want to minimise the number of clinic visits required. Our pharmacists at Perfect Meds routinely administer multiple travel vaccines in a single appointment, tailoring the schedule to ensure that all required vaccines are administered in the most efficient and effective sequence possible.
- The hepatitis A vaccine can be given at the same time as hepatitis B, typhoid, yellow fever, rabies, meningitis, and diphtheria/tetanus/polio vaccines without any loss of efficacy.
- When given simultaneously with other vaccines, each injection should be administered at a different site, typically different arms or different sites on the same arm, to allow accurate attribution of any injection site reactions.
- The hepatitis A component of combination vaccines (Twinrix, Hepatyrix, ViATIM) behaves in the same way as the standalone hepatitis A vaccine and can be co-administered with other required vaccines in the same appointment.
- Antimalarial medications do not interfere with the hepatitis A vaccine, meaning that travellers who require both can receive the vaccine and begin their antimalarial course simultaneously without any clinical concern.
Hepatitis A Vaccine Safety and Side Effects
The hepatitis A vaccine has an excellent and extensively documented safety record built over more than three decades of routine use in the UK and globally. As an inactivated vaccine, it does not contain live virus and cannot cause hepatitis A infection. It is considered safe for use across a very wide range of patient groups including immunocompromised individuals, older adults, and pregnant women; though as with all vaccines in pregnancy, the decision to vaccinate should follow a careful risk-benefit assessment in consultation with a healthcare professional.
Common and Less Common Side Effects
- Soreness, redness, or mild swelling at the injection site; the most frequently reported reaction, occurring in a significant proportion of recipients and typically resolving within two to three days without any specific treatment.
- Mild headache, fatigue, or low-grade fever in a proportion of recipients, usually short-lived and resolving without intervention within 24 to 48 hours.
- Occasional mild nausea, loss of appetite, or general malaise in the days following vaccination, particularly after the first dose.
- Serious allergic reactions (anaphylaxis) are extremely rare; recipients should remain at the vaccination centre for at least 15 minutes after each dose so that any immediate reactions can be identified and managed promptly.
- The hepatitis A vaccine has not been credibly associated with any serious long-term adverse effects in the extensive clinical trial and post-marketing surveillance data available to date.
Hepatitis A Vaccination in Pregnancy and for Children
The hepatitis A vaccine is an inactivated vaccine and is therefore considered safe for use during pregnancy when the risk of hepatitis A exposure is considered significant. There is no theoretical mechanism by which an inactivated vaccine could cause harm to a developing foetus, and the risk of hepatitis A infection during pregnancy, which can cause more severe illness in pregnant women and may be associated with an increased risk of preterm delivery, may in many cases outweigh any theoretical concern about vaccination. However, as with all health decisions during pregnancy, vaccination should be discussed with a healthcare professional who can provide personalised advice based on the individual’s specific travel plans and health history.
The hepatitis A vaccine is suitable for children from the age of one year and over, using the same dosing schedule as for adults; a primary dose followed by a booster six to twelve months later. Children travelling to hepatitis A endemic regions with their families are encouraged to be vaccinated, as they may be particularly vulnerable to exposure through play, contact with local children, and the difficulty of consistently applying food and water hygiene precautions in young children. Vaccination of all eligible family members before travel to a high-risk destination is strongly advisable, and a pharmacist at Perfect Meds can advise on the most appropriate schedule for each member of your travel party.
Families travelling to a hepatitis A endemic region should ensure that every eligible member of the travel party is vaccinated well before departure, including children aged one year and over. Contact us to book a family travel health consultation and get everyone protected in a single convenient visit.
Food and Water Safety Alongside the Hepatitis A Vaccine
Whilst the hepatitis A vaccine is highly effective, it does not provide protection against all of the foodborne and waterborne pathogens that travellers to endemic regions may encounter, including typhoid fever, cholera, traveller’s diarrhoea caused by bacteria such as E. coli, and parasitic infections such as Giardia and Cryptosporidium. Food and water hygiene precautions are therefore an essential complement to hepatitis A vaccination and should be practised consistently throughout any trip to a high-risk destination.
- Drink only bottled, boiled, or chemically treated water; avoid tap water, ice in drinks, and unbottled water, including when brushing teeth in high-risk destinations.
- Eat only thoroughly cooked food that is served hot; avoid raw or undercooked shellfish, which are a particularly high-risk vehicle for hepatitis A transmission due to their filter-feeding habits in potentially contaminated coastal waters.
- Avoid raw fruits and vegetables that cannot be peeled, and wash any produce you do prepare yourself in treated water.
- Apply the principle of “boil it, cook it, peel it, or leave it” as a practical daily guide to safe food choices in endemic regions.
- Wash hands thoroughly with soap and water before eating and after using the toilet; where handwashing facilities are not available, use an alcohol-based hand sanitiser as a temporary measure, though note that hand sanitiser is not effective against all relevant pathogens including hepatitis A virus in some circumstances.
Frequently Asked Questions
From understanding how long the hepatitis A vaccine lasts to knowing whether a booster is needed before your next trip, these answers to the most common questions about the hepatitis A vaccine will help you make a confident and well-informed decision about your travel health.
Do I need a hepatitis A booster before every trip to a high-risk destination?
No. If you have completed the full two-dose course of the hepatitis A vaccine, you are considered to have long-term and likely lifelong protection and do not require a booster before each trip. If you have only received the first dose and your protection window of approximately one year has elapsed, a single booster dose will complete your long-term protection without the need to restart the course from scratch.
How soon before travel should I get the hepatitis A vaccine?
The hepatitis A vaccine should ideally be administered at least two weeks before travel to allow the immune system sufficient time to develop a protective response before arrival in a high-risk area. However, even a vaccine given on the day of departure will provide some protection and is better than travelling unvaccinated; a pharmacist can advise on the most appropriate approach if your departure date is approaching.
Is the hepatitis A vaccine available on the NHS?
The hepatitis A vaccine is available on the NHS for individuals who meet specific eligibility criteria, including those with chronic liver disease, men who have sex with men, people who inject drugs, and certain occupational groups. For the majority of travellers who do not meet NHS eligibility criteria, the vaccine is available privately through registered pharmacies and travel clinics such as Perfect Meds.
Can I have the hepatitis A vaccine if I have already had hepatitis A?
If you have previously had confirmed hepatitis A infection, you are likely to have developed natural immunity that provides long-term protection against re-infection. A blood test to confirm the presence of hepatitis A antibodies can establish whether natural immunity is present; if it is confirmed, vaccination is not required, and a pharmacist can advise on whether testing is worthwhile in your specific circumstances.
Is there any difference between the standalone hepatitis A vaccine and the combination vaccines?
The hepatitis A component in combination vaccines such as Twinrix and Hepatyrix works in the same way and provides the same duration of protection as the standalone hepatitis A vaccine, and the dosing schedule for the hepatitis A component follows the same principles. The primary practical difference is that combination vaccines provide protection against additional diseases simultaneously, reducing the number of separate injections required; a pharmacist can advise on whether a combination vaccine is the most appropriate option for your itinerary.
Can the hepatitis A vaccine be given to someone who is immunocompromised?
Yes. As an inactivated vaccine, the hepatitis A vaccine is safe for immunocompromised individuals and does not carry the risk associated with live vaccines in this group. However, immunocompromised individuals may mount a reduced immune response to the vaccine and may not achieve the same level of protection as healthy recipients; a pharmacist or GP can advise on whether additional doses or post-vaccination antibody testing is recommended in specific cases.
Long-Lasting Protection Against Hepatitis A
The hepatitis A vaccine offers some of the longest-lasting protection of any travel vaccine available; a two-dose course completed over six to twelve months provides at least 25 years of cover and likely lifelong immunity for most recipients, with no further routine boosters required. For travellers who visit hepatitis A endemic regions regularly, this represents an exceptional return on a one-time health investment that eliminates the need for repeat vaccination before every trip for the rest of their travelling life.
Whether you need your first hepatitis A dose before an upcoming trip, a long-overdue booster, a vaccination history review, or a full travel health consultation covering everything your destination requires, our expert pharmacists at Perfect Meds are here to make the process as straightforward and accessible as possible. Book now to get your hepatitis A vaccination sorted and travel to your next destination with the complete confidence that comes from knowing you are fully protected.
Medical Disclaimer: The information provided in this article is intended for general informational purposes only and does not constitute medical advice. Individual circumstances vary, and you should always speak to a qualified medical professional or pharmacist before starting any vaccination, treatment, or health programme. If you have any concerns about your health or suitability for any vaccine, please consult your GP or a registered healthcare provider before proceeding.
